Crossmark

The Importance of Assessing Drug Exposure and Medication Adherence in Evaluating Investigational Medications: Ensuring Validity and Reliability of Clinical Trial Results

Crossref DOI link: https://doi.org/10.1007/s40290-023-00503-w

Published Online: 2023-12-22

Published Print: 2024-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Vrijens, Bernard http://orcid.org/0000-0002-9090-1253
Pironet, Antoine

Tousset, Eric
License Information

Text and Data Mining valid from 2023-12-22

Version of Record valid from 2023-12-22
More Information

Article History

Accepted: 3 October 2023

First Online: 22 December 2023

Declarations

:

: No funding was received for this work.

: All authors are employees of AARDEX Group. BV is a shareholder of AARDEX Group.

: Not applicable.

: Not applicable.

: All authors contributed to drafting and revising the article, provided their final approval of all content, and agree to be accountable for all aspects of the work.

: Not applicable.

: Not applicable.

: Not applicable.

Document is current

Any future updates will be listed below